Trade Summary

1 month ago, Patel Mahesh V., serving as CEO at Lipocine Inc. (LPCN), purchased 25,000 shares at $2.02 per share, for a total transaction value of $50,500.00. Following this transaction, Patel Mahesh V. now holds 135,679 shares of LPCN.

This purchase represents a 23.00% increase in Patel Mahesh V.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, April 2, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, April 2, 2026 at 5:05 PM ET, meaning the disclosure happened on the same day as the trade.

Lipocine Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.